Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted [1,2,4]triazolo[4,3-A]pyrazines that are BRD4 inhibitors

Substituted [1,2,4]triazolo[4,3-A]pyrazines that are BRD4 inhibitors

US Patent 9266891 · Granted Feb 23, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted 1H-pyrazolo[4,3-c]pyridines and derivatives as EGFR inhibitors2024
Annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancer2024
Annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancer2024
Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors2023
[1,6]naphthyridine compounds and derivatives as CDK8/CDK19 inhibitors2022
Phenylpyrazolylacetamide compounds and derivatives as CDK8/CDK19 inhibitors2022
Benzimidazole compounds and derivatives as EGFR inhibitors2021
Triazolopyrazine2021
Triazolopyrazine2021
Triazolopyrazine2021
Substituted [1,2,4]triazolo[4,3-a]pyrazines as BRD4 inhibitors2019
Substituted [1,2,4]triazolo[4,3-a]pyrazines as BRD4 inhibitors2019